openPR Logo
Press release

Lung Cancer Diagnostics Market Expansion Driven by Liquid Biopsy Demand and Early Detection Initiatives 2025-2033 | F. Hoffmann-La Roche Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical

07-16-2025 01:39 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Lung Cancer Diagnostics Market

Lung Cancer Diagnostics Market

The global lung cancer diagnostics market reached US$ 4.94 billion in 2024 and is expected to reach US$ 8.44 billion by 2033, growing at a CAGR of 6.18% during the forecast period 2025-2033.

Lung Cancer Diagnostics Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-diagnostics-market?ophp

Lung cancer diagnostics include imaging, biomarker testing, and molecular diagnostics used for early detection and subtype classification. The market is expanding due to rising lung cancer prevalence, adoption of liquid biopsies and NGS, and the growing importance of companion diagnostics for targeted therapies.

Lung Cancer Diagnostics Market Competitors Overview:

Quest Diagnostics Incorporated, Biodesix, Lepu Medical Technology (Beijing)Co., Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical, bioAffinity Technologies, Inc., Optellum Ltd and F. Hoffmann-La Roche Ltd. among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In January 2025, Monitor Corporation has begun selling its lung cancer diagnosis software in Japan through a partnership with Doctor-NET, a Japanese digital healthcare provider.

Methodology and Scope

The Lung Cancer Diagnostics Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-cancer-diagnostics-market?ophp

Lung Cancer Diagnostics Market Segments Overview:

∎ By Type (Small Cell Lung Cancer (Small Cell Carcinoma, Combined Small Cell Carcinoma), Non-small Cell Lung Cancer (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Others)
∎ By Diagnosis (Imaging Tests, Sputum Cytology, Biopsy, Biomarker Testing, Others)
∎ By End User (Hospitals, Diagnostic Centers, Others)

Regional Overview for Lung Cancer Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=lung-cancer-diagnostics-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Diagnostics Market Expansion Driven by Liquid Biopsy Demand and Early Detection Initiatives 2025-2033 | F. Hoffmann-La Roche Ltd., DSS Imagetec, Abbott, Guardant Health, Intuitive Surgical here

News-ID: 4106439 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Orthopaedic Implants Market to Reach USD 71.6 billion by 2030, Driven by Rising Geriatric Population and Sports Injuries | DataM Intelligence
United States Orthopaedic Implants Market to Reach USD 71.6 billion by 2030, Dri …
The global Orthopaedic Implants Market reached USD 44.7 billion in 2022 and is projected to reach USD 71.6 billion by 2030, growing at a CAGR of 6.2% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Zimmer Biomet raised its annual profit forecast, driven by strong demand for hip and knee implants and advancements in robotic-assisted surgical systems. ✅ In August 2025, Exactech
United States Viral Inactivation Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Viral Inactivation Market 2025 | Growth Drivers, Key Players & Inv …
Market Size and Growth Viral Inactivation Market is expected to grow at a CAGR of 11.0% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments ✅ In May 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The incidence rate also rose from 2.5 per 100,000 individuals in 2022
Bone Broth Protein Market Outlook 2025-2032
Bone Broth Protein Market Outlook 2025-2032
The global bone broth protein supplement market reached US$89.99million in 2024 and is expected to reach US$165.34million by 2032, growing at a CAGR of 7.9% during the forecast period 2025-2032. The market includes protein supplements made from simmered animal bones, rich in collagen, supporting joint, muscle, skin, and gut health, driven by demand for natural, functional nutrition. 📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Bone Broth
Nebulizer Market Growth & Trends 2025-2033
Nebulizer Market Growth & Trends 2025-2033
The global inhalation therapy nebulizer market was valued at US$1.15 B in 2024 and is projected to reach US$4.52 B by 2033, growing at a CAGR of 7.8% from 2025 to 2033. The market covers devices that deliver medication as a mist directly into the lungs to treat respiratory diseases like asthma, COPD, and cystic fibrosis. Growth is driven by rising respiratory disorders, technological innovations, and expanding healthcare access. 📌 Download Sample

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor